Exacerbations and Real-World Outcomes Among Patients With Chronic Obstructive Pulmonary Disease Following Severe Exacerbation

NCT07414134 · clinicaltrials.gov ↗

COMPLETED

Status

3598

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: BGF- BUDESONIDE/GLYCOPYRRONIUM/FORMOTEROL

Sponsor

AstraZeneca